Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MCR MINI-UPDATE JANUARY 2013 Fellow Registrars, The year 2013 is upon us! Fortunately, as you will see below, it will not bring many changes from the standard setters. Hopefully this will give us all a chance to get caught up and catch our breath. Please share this with others who do not receive it. Let me know if you have any questions. 2013 CHANGES AT MCR Casefinding List Review of the facility Medical Record Disease Index (MRDI) is essential to accomplishing complete cancer casefinding (see MCR Manual Chapter 2 for details). In the past, MCR has customized its own tool based on the SEER published list. This year, the 2013 SEER tool is provided directly to assist you in determining which codes to include in your facility’s MRDI: http://seer.cancer.gov/tools/casefinding/ The expanded version accommodates either ICD-9-CM or ICD-10_CM codes. MCR recommends that you use the codes on the Comprehensive section of the list and add as many codes from the Supplemental section as prove useful at your facility. Please share your decisions with the programmers who help you sift through billing codes at your facility so that it can be implemented with 2013 casefinding. Required Data Elements The table of MCR Required Data Elements has been updated for 2013 and posted to the MCR website. It will be provided to your software vendor for incorporation into NAACCR v13 software upgrades and database conversions. Changes are noted on the posted table and include: First Course Calc Method - this field has been retired by NAACCR; look for more specific details on this in a future update. There are some new data items for recording state and country separately as part of a standardization/interoperability initiative. Fortunately, vendors are being encouraged to have country automatically fill based on the state or province entry. Historic codes related to Place of Birth and Death will be replaced during software conversion. Look-up tables will provide codes for the new fields. The Ambiguous Terminology field is no longer required for new cases, although the ambiguous terms themselves remain important for determining case and primary reportability. RX Date data items changed in name only so that closely-related items would be adjacent in alphabetical listings. Unusual Follow-up Method is now a 2 digit field to allow additional codes needed by central registries. There are no changes to Missouri-specific fields. Upcoming Edits and Conversions The NAACCR edit metafile v13 was released in mid-December. I will customize it for Missouri and forward it to the hospital registry software vendors to incorporate into their upgrades that you will use in converting your database to NAACCR v13 during 2013. I will provide details on the edit metafile and timing announcements regarding our conversion of Web Plus to NAACCR v13 layout in a future monthly update. Our central registry software vendor currently anticipates that conversion of the MCR database will occur no earlier than April. MCR Manual The MCR Abstract Coding Manual will be revised this winter now that FORDS 2013 was recently published. Watch for an announcement in a future monthly update. EDUCATION NAACCR Webinars – are trainings that are held here in our offices the first Thursday of each month for 3-4 hours, which typically begin at 8am and are presented by NAACCR Staff. MCR-ARC is only a host site for the telecast of the webinar. January 10, 2013 - Collecting Cancer Data: Bone and Soft Tissue Recorded Webinars are now available to view. Request Access Now! Check out our Education and Training page to find out how you can receive access to previously recorded NAACCR Webinars including Uterus, Stomach and Esophagus, Pharynx. Live Meetings - are trainings which are viewed from your computer on the second Wednesday of each month, are usually one hour long, begin at 10am and are presented by MCR-ARC Staff. January 9, 2013 - Surgery Coding for Skin Primaries, by Angela Martin. February 13, 2013 - Multiple Primary and Histology General Rules Overview, by Deb Smith As always, to register for any of our educational opportunities, contact Shari El Shoubasi at [email protected] or 1-866-240-8809. Please be sure to clarify which session you will be attending when you register. ABSTRACTING TIPS Abstracting Tip – Cervix Histology code 8384 (Adenocarcinoma, endocervical type) should not be used to code Adenocarcinoma, NOS that arises in the cervix. Adenocarcinoma, endocervical type is a specific histologic type which is coded only when it is a part of the final pathologic diagnosis. Use histology code 8140 for Adenocarcinoma, NOS that arises in the cervix. Abstracting Tip – Endometriod vs. Endometrial When abstracting histologic type for endometrial primaries, be careful not to confuse the terminology, “endometrioid” adenocarcinoma and “endometrial” adenocarcinoma. “Endometrioid” refers to a specific subtype of adenocarcinoma, while “endometrial” adenocarcinoma signifies adenocarcinoma, NOS arising from the endometrium. Please be certain to use the correct term when documenting the pathology diagnosis in your text. Abstracting Tip – Overlapping Sites When a primary tumor extends to occupy adjacent subsites, remember to code the primary site as the subsite in which the tumor originated rather than assign an “overlapping sites” code. The .8 subsite code should be used only when the primary tumor involves adjacent sites and it’s not possible to determine its point of origin. In your text, please name the overlapping sites represented by the primary site code rather than merely enter “overlapping sites.” STANDARD SETTER NEWS CoC Update on Assigning Class of Case in the Age of Mergers http://newsmanager.commpartners.com/acscoc/issues/2012-12-07/7.html CODING UPDATES There will be no 2013 changes for Collaborative Stage v2.04 or Multiple Primary & Histology Coding Rules! Next changes for them are scheduled for 2014 and 2015, respectively. FORDS 2013 was just released and is available at http://www.facs.org/cancer/coc/fordsmanual.html. Until you begin abstracting 2013 cases and upgrade to NAACCR v13, it is good to check to assure that you have the most current versions of coding instructions for 2012: FORDS If you need to reference FORDS, be sure you have downloaded FORDS 2012c which is updated through 6/29/12. Appendix C documents the changes since 1/1/12: Class of Case, second example code corrected to 13 Type of Multiple Tumors Reported as One Primary, typo codes 13 and 14 corrected to 20 and 30 Multiplicty Counter – code 88 added for C80.9 Radiation/Surgery Sequence and Systemic Surgery Sequence, code 4 definitions corrected, see FORDS Appendix B Breast Surgery code note about contralateral cancers corrected to specify either code 41 or 51 in cases with contralateral primaries. MP/H The Multiple Primary and Histology Manual was updated 8/24/12. See an outline of the changes at: http://seer.cancer.gov/tools/mphrules/revisions.html Hematopoietic and Lymphoid Neoplasm Rules Last released in April 2012, the web version is recommended for automatic access to updates. The stand alone is currently dated 5/23/2012. SEER Rx Interactive Drug Database Last released in May 2012, the web version is recommended for automatic access to updates. The stand alone is currently dated 5/7/2012. Occupation and Industry Reporting Facilities should have reviewed the pamphlet at http://www/cdc/gov/niosh/docs/2011-173 and be applying these principles to text they enter on abstracts. Answers to Coding Dilemmas in CSv0204 Do you have a case where none of the CS codes seems right for your scenario? It is probably a known issue, and one that the CS team is addressing for version 02.05. In the meantime, CS has developed a document to help you, and it is posted on the home page at http://www.cancerstaging.org/cstage/CSv0204-support-known.pdf The “CSv0204 Support for Identified Issues” is an important resource. This provides registrars coding guidelines for the key issues identified in the current version, 0204, that will be fixed in the next release. The list is brief, as we try to keep it to the most important issues, or those affecting a large number of cases. If your issue isn’t there, please use the search feature in the CAnswer Forum to find the guidance you need. If you topic has not yet been addressed, you may submit it the CAnswer Forum for assistance. CS Website Check out the recently added education presentations page http://www.cancerstaging.org/cstage/education/presentations.html This page includes the CS presentations from the 2012 and 2011 NCRA meetings for anyone to download. The page also contains the PowerPoint slides, the handouts, the quiz and the answer sheets for the seven CS webinars available on the AJCC Education Portal. These materials have been made available so that all registrars may have access to these important educational resources. Recruitment and Retention of CTRs NCRA has produced a series of PowerPoint presentations along with notes that can be used if you see a need to present this topic locally. http://www.ncra-usa.org/i4a/pages/index.cfm?pageid=3763 American Cancer Society Journals CA: A Cancer Journal for Clinicians offers information on cancer prevention, early detection, treatment, palliation, advocacy, quality of life, and other areas essential for clinicians and healthcare professionals working on the front lines of oncology care. The journal’s content is available online without a subscription. Cancer publishes the latest peer-reviewed articles covering all oncologic disciplines for physicians and researchers and the Annual Report to the Nation every other year. The journal’s content is offered for free online 12 months after publication and abstracts can be viewed for free. Cancer publishes all content online ahead of print. Cancer Cytopathology publishes the latest peer-reviewed articles in cytopathology and related oncologic disciplines for physicians and researchers. Content is offered for free online 12 months after publication and abstracts can be viewed for free. Cancer Cytopathology publishes all content online ahead of print. ACS Guidelines and Patient Pages gives you access to the most up-to-date cancer guidelines published in CA. This publication can be obtained free online. To view the flipbook, go to cacancerjournal.com and look on the left side bar under Special Features. For access to all of these journals, please visit online at acsjournals.com. Central Brain Tumor Registry of the United States The Central Brain Tumor Registry of the U.S. (CBTRUS) announces the publication by Oxford University Press of its latest report, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009. The report is a supplement to the Society for NeuroOncology's official journal, Neuro-Oncology, and is available free to view on the CBTRUS website at www.cbtrus.org by clicking on Reports and Tables. Data collected by the Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR) and the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) program from 49 population-based cancer registries were analyzed, revealing an incidence rate of 20.59 cases per 100,000 for all primary brain and central nervous system tumors in 2005–2009. The efforts of hospital tumor registrars, central cancer registries, and staff from NPCR and SEER to collect accurate and complete data have contributed to making this report possible. A limited number of printed booklets may be requested by contacting [email protected]. RESOURCES The 10 Commandments of Windows Security http://www.csoonline.com/article/704788/10-commandments-of-windows-security Molecular Profiling for Unknown Primaries to Predict Tissue of Origin and Specific Therapy http://jco.ascopubs.org/content/early/2012/10/01/JCO.2012.43.3755.abstract?sid=b529c2f9-daaa46f3-9cf1-bb04401ea289 Should Premenopausal breast cancer patients take tamoxifen for 10 years? Results of the ATLAS study: http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2990 Is Axillary Node dissection important for survival when SLN are positive? Results of ACOSOG Z0011: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=74&abstractID= 47842 Associated NCCN guideline: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf A blog re-cap of triple negative breast cancer research: http://curetoday.com/index.cfm/fuseaction/blog.showIndex/guest/2012/12/9/A-recap-oftriplenegative-breast-cancer-research-from-San-Antonio A potential breakthrough in the treatment of triple negative breast cancer? http://curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/6/8/PARP-inhibitorscreate-buzz-at-ASCO Wishing you much success and satisfaction in the new year, Nancy H. Rold, CTR QA Unit Supervisor Missouri Cancer Registry and Research Center